questionsmedicales.fr
Phénomènes psychologiques
Processus mentaux
Perception
Perception visuelle
Perception visuelle : Questions médicales fréquentes
Termes MeSH sélectionnés :
Interferon-gamma Release Tests
Diagnostic
5
Évaluation de la vision
Tests de vision
Imagerie par résonance magnétique
Électrorétinogramme
Troubles de la vision
Illusions visuelles
Ophtalmologie
Changements de vision
Maladies oculaires
Traumatismes oculaires
Symptômes
5
Vision floue
Difficultés de profondeur
Illusions visuelles
Perception visuelle
Agnosie
Troubles de la perception
Fatigue visuelle
Maux de tête
Synesthésie
Perception sensorielle
Prévention
5
Prévention des troubles visuels
Lunettes de soleil
Fatigue visuelle
Utilisation d'écrans
Tabagisme
Dégénérescence maculaire
Exercice physique
Santé oculaire
Traitements
5
Thérapie visuelle
Chirurgie oculaire
Thérapie visuelle
Coordination œil-main
Lunettes
Erreurs de réfraction
Chirurgie de la cataracte
Glaucome
Médicaments ophtalmiques
Glaucome
Complications
5
Perte de vision
Troubles émotionnels
Activités quotidiennes
Mobilité
Dépression
Isolement social
Aggravation des troubles
Traitement
Agnosie
Interactions sociales
Facteurs de risque
5
Âge
Antécédents familiaux
Diabète
Rétinopathie diabétique
Hypertension
Vaisseaux sanguins
Traumatismes oculaires
Risques visuels
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Perception visuelle : Questions médicales les plus fréquentes",
"headline": "Perception visuelle : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Perception visuelle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-29",
"dateModified": "2025-04-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Perception visuelle"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Perception",
"url": "https://questionsmedicales.fr/mesh/D010465",
"about": {
"@type": "MedicalCondition",
"name": "Perception",
"code": {
"@type": "MedicalCode",
"code": "D010465",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Clignement attentionnel",
"alternateName": "Attentional Blink",
"url": "https://questionsmedicales.fr/mesh/D054518",
"about": {
"@type": "MedicalCondition",
"name": "Clignement attentionnel",
"code": {
"@type": "MedicalCode",
"code": "D054518",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.145"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Perception des couleurs",
"alternateName": "Color Perception",
"url": "https://questionsmedicales.fr/mesh/D003118",
"about": {
"@type": "MedicalCondition",
"name": "Perception des couleurs",
"code": {
"@type": "MedicalCode",
"code": "D003118",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.217"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Perception du mouvement",
"alternateName": "Motion Perception",
"url": "https://questionsmedicales.fr/mesh/D009039",
"about": {
"@type": "MedicalCondition",
"name": "Perception du mouvement",
"code": {
"@type": "MedicalCode",
"code": "D009039",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.567"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Reconnaissance visuelle des formes",
"alternateName": "Pattern Recognition, Visual",
"url": "https://questionsmedicales.fr/mesh/D010364",
"about": {
"@type": "MedicalCondition",
"name": "Reconnaissance visuelle des formes",
"code": {
"@type": "MedicalCode",
"code": "D010364",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.622"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Reconnaissance faciale",
"alternateName": "Facial Recognition",
"url": "https://questionsmedicales.fr/mesh/D000066499",
"about": {
"@type": "MedicalCondition",
"name": "Reconnaissance faciale",
"code": {
"@type": "MedicalCode",
"code": "D000066499",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.622.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Clôture perceptive",
"alternateName": "Perceptual Closure",
"url": "https://questionsmedicales.fr/mesh/D010466",
"about": {
"@type": "MedicalCondition",
"name": "Clôture perceptive",
"code": {
"@type": "MedicalCode",
"code": "D010466",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.677"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vision binoculaire",
"alternateName": "Vision, Binocular",
"url": "https://questionsmedicales.fr/mesh/D015348",
"about": {
"@type": "MedicalCondition",
"name": "Vision binoculaire",
"code": {
"@type": "MedicalCode",
"code": "D015348",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.885"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vision monoculaire",
"alternateName": "Vision, Monocular",
"url": "https://questionsmedicales.fr/mesh/D015349",
"about": {
"@type": "MedicalCondition",
"name": "Vision monoculaire",
"code": {
"@type": "MedicalCode",
"code": "D015349",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.893"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Perception visuelle",
"alternateName": "Visual Perception",
"code": {
"@type": "MedicalCode",
"code": "D014796",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "J Farley Norman",
"url": "https://questionsmedicales.fr/author/J%20Farley%20Norman",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychological Sciences, Ogden College of Science and Engineering, Western Kentucky University, 1906 College Heights Blvd. #22030, Bowling Green, KY, 42101-2030, USA. farley.norman@wku.edu."
}
},
{
"@type": "Person",
"name": "Matan Mazor",
"url": "https://questionsmedicales.fr/author/Matan%20Mazor",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK."
}
},
{
"@type": "Person",
"name": "Rani Moran",
"url": "https://questionsmedicales.fr/author/Rani%20Moran",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neurology, Max Planck UCL Centre for Computational Psychiatry and Ageing Research, London, UK."
}
},
{
"@type": "Person",
"name": "Stephen M Fleming",
"url": "https://questionsmedicales.fr/author/Stephen%20M%20Fleming",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK."
}
},
{
"@type": "Person",
"name": "Johan Wagemans",
"url": "https://questionsmedicales.fr/author/Johan%20Wagemans",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Experimental Psychology, Department of Brain and Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Tiensestraat 102 - box 3711, 3000, Leuven, Belgium."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Differentially expressed transcript isoforms associate with resistance to tuberculin skin test and interferon gamma release assay conversion.",
"datePublished": "2023-04-14",
"url": "https://questionsmedicales.fr/article/37058459",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0284498"
}
},
{
"@type": "ScholarlyArticle",
"name": "Monocyte Transcriptional Responses to Mycobacterium tuberculosis Associate with Resistance to Tuberculin Skin Test and Interferon Gamma Release Assay Conversion.",
"datePublished": "2022-06-13",
"url": "https://questionsmedicales.fr/article/35695527",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/msphere.00159-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of an Interferon-Gamma Release Assay (IGRA) to Aid Diagnosis of Histoplasmosis.",
"datePublished": "2022-10-03",
"url": "https://questionsmedicales.fr/article/36190260",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/jcm.01128-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Serial testing of latent tuberculosis infection in patients with diabetes mellitus using interferon-gamma release assay, tuberculin skin test, and creation tuberculin skin test.",
"datePublished": "2022-12-01",
"url": "https://questionsmedicales.fr/article/36530654",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2022.1025550"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation comparing tuberculin skin test and interferon-gamma release assay.",
"datePublished": "2023-05-01",
"url": "https://questionsmedicales.fr/article/37126131",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10096-023-04613-w"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes psychologiques",
"item": "https://questionsmedicales.fr/mesh/D011579"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus mentaux",
"item": "https://questionsmedicales.fr/mesh/D008606"
},
{
"@type": "ListItem",
"position": 4,
"name": "Perception",
"item": "https://questionsmedicales.fr/mesh/D010465"
},
{
"@type": "ListItem",
"position": 5,
"name": "Perception visuelle",
"item": "https://questionsmedicales.fr/mesh/D014796"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Perception visuelle - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Perception visuelle",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Perception visuelle",
"description": "Comment évaluer la perception visuelle ?\nQuels examens pour troubles de la perception ?\nQuels signes indiquent un problème visuel ?\nQuand consulter un spécialiste de la vue ?\nQuelles sont les causes de troubles visuels ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Interferon-gamma+Release+Tests#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Perception visuelle",
"description": "Quels symptômes de troubles de la perception ?\nComment reconnaître une illusion visuelle ?\nQu'est-ce que l'agnosie visuelle ?\nQuels signes d'une fatigue visuelle ?\nComment se manifeste la synesthésie visuelle ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Interferon-gamma+Release+Tests#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Perception visuelle",
"description": "Comment prévenir les troubles de la perception ?\nQuel rôle joue l'alimentation sur la vision ?\nComment réduire la fatigue visuelle ?\nPourquoi éviter le tabac pour la vision ?\nL'exercice physique aide-t-il la vision ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Interferon-gamma+Release+Tests#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Perception visuelle",
"description": "Quels traitements pour troubles de la perception ?\nComment la thérapie visuelle aide-t-elle ?\nLes lunettes corrigent-elles la perception ?\nQuand envisager une chirurgie oculaire ?\nQuels médicaments pour troubles visuels ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Interferon-gamma+Release+Tests#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Perception visuelle",
"description": "Quelles complications des troubles visuels ?\nComment les troubles visuels affectent-ils la vie quotidienne ?\nQuels risques de dépression avec troubles visuels ?\nLes troubles de la perception peuvent-ils s'aggraver ?\nQuelles sont les conséquences d'une agnosie visuelle ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Interferon-gamma+Release+Tests#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Perception visuelle",
"description": "Quels facteurs de risque pour troubles visuels ?\nLe diabète augmente-t-il les risques visuels ?\nComment l'hypertension affecte-t-elle la vision ?\nLe stress influence-t-il la perception visuelle ?\nLes antécédents de traumatismes oculaires sont-ils un risque ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Interferon-gamma+Release+Tests#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la perception visuelle ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de vision, comme l'optométrie, évaluent la perception visuelle."
}
},
{
"@type": "Question",
"name": "Quels examens pour troubles de la perception ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM et l'électrorétinogramme aident à diagnostiquer les troubles de la perception."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un problème visuel ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des difficultés à voir, des illusions ou des distorsions visuelles peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Quand consulter un spécialiste de la vue ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un ophtalmologiste si vous ressentez des changements soudains de vision."
}
},
{
"@type": "Question",
"name": "Quelles sont les causes de troubles visuels ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les causes incluent les maladies oculaires, les traumatismes et les troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes de troubles de la perception ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la vision floue, les halos, et les difficultés de profondeur."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une illusion visuelle ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les illusions visuelles se manifestent par des perceptions erronées d'objets ou de couleurs."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'agnosie visuelle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'agnosie visuelle est l'incapacité de reconnaître des objets malgré une vision intacte."
}
},
{
"@type": "Question",
"name": "Quels signes d'une fatigue visuelle ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des maux de tête, des yeux secs et une vision floue après un usage prolongé."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la synesthésie visuelle ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La synesthésie visuelle se manifeste par des associations involontaires entre couleurs et sons."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles de la perception ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Protégez vos yeux avec des lunettes de soleil et faites des examens réguliers."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation sur la vision ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en vitamines A, C et E peut aider à maintenir une bonne vision."
}
},
{
"@type": "Question",
"name": "Comment réduire la fatigue visuelle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Faites des pauses régulières lors de l'utilisation d'écrans pour réduire la fatigue visuelle."
}
},
{
"@type": "Question",
"name": "Pourquoi éviter le tabac pour la vision ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabac augmente le risque de maladies oculaires comme la dégénérescence maculaire."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il la vision ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la circulation sanguine, bénéfique pour la santé oculaire."
}
},
{
"@type": "Question",
"name": "Quels traitements pour troubles de la perception ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie visuelle, les lunettes et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "Comment la thérapie visuelle aide-t-elle ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie visuelle améliore la coordination œil-main et la perception visuelle."
}
},
{
"@type": "Question",
"name": "Les lunettes corrigent-elles la perception ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les lunettes corrigent les erreurs de réfraction et améliorent la perception visuelle."
}
},
{
"@type": "Question",
"name": "Quand envisager une chirurgie oculaire ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée pour des problèmes structurels comme la cataracte ou le glaucome."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour troubles visuels ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent traiter des conditions comme le glaucome ou les infections oculaires."
}
},
{
"@type": "Question",
"name": "Quelles complications des troubles visuels ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de vision, l'isolement social et des troubles émotionnels."
}
},
{
"@type": "Question",
"name": "Comment les troubles visuels affectent-ils la vie quotidienne ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent limiter les activités quotidiennes, affecter le travail et la mobilité."
}
},
{
"@type": "Question",
"name": "Quels risques de dépression avec troubles visuels ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les troubles visuels augmentent le risque de dépression en raison de l'isolement social."
}
},
{
"@type": "Question",
"name": "Les troubles de la perception peuvent-ils s'aggraver ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, certains troubles de la perception peuvent s'aggraver avec le temps."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une agnosie visuelle ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'agnosie visuelle peut entraîner des difficultés dans la reconnaissance d'objets et des interactions sociales."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour troubles visuels ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, les antécédents familiaux et les maladies chroniques."
}
},
{
"@type": "Question",
"name": "Le diabète augmente-t-il les risques visuels ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut causer des complications oculaires comme la rétinopathie diabétique."
}
},
{
"@type": "Question",
"name": "Comment l'hypertension affecte-t-elle la vision ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypertension peut endommager les vaisseaux sanguins de l'œil, entraînant des troubles visuels."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la perception visuelle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affecter la concentration et la clarté de la perception visuelle."
}
},
{
"@type": "Question",
"name": "Les antécédents de traumatismes oculaires sont-ils un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traumatismes oculaires augmentent le risque de troubles de la perception visuelle."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 24/04/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Department of Psychological Sciences, Ogden College of Science and Engineering, Western Kentucky University, 1906 College Heights Blvd. #22030, Bowling Green, KY, 42101-2030, USA. farley.norman@wku.edu.
Center for Applied Science in Health and Aging, Western Kentucky University, Bowling Green, KY, 42101-2030, USA. farley.norman@wku.edu.
Publications dans "Perception visuelle" :
3 publications dans cette catégorie
Affiliations :
Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK.
Publications dans "Perception visuelle" :
3 publications dans cette catégorie
Affiliations :
Institute of Neurology, Max Planck UCL Centre for Computational Psychiatry and Ageing Research, London, UK.
Publications dans "Perception visuelle" :
3 publications dans cette catégorie
Affiliations :
Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK.
Institute of Neurology, Max Planck UCL Centre for Computational Psychiatry and Ageing Research, London, UK.
Department of Experimental Psychology, University College London, London, UK.
Publications dans "Perception visuelle" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Experimental Psychology, Department of Brain and Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Tiensestraat 102 - box 3711, 3000, Leuven, Belgium.
Publications dans "Perception visuelle" :
2 publications dans cette catégorie
Affiliations :
Humboldt-Universität zu Berlin, Berlin, Germany.
Publications dans "Perception visuelle" :
2 publications dans cette catégorie
Publications dans "Perception visuelle" :
2 publications dans cette catégorie
Publications dans "Perception visuelle" :
2 publications dans cette catégorie
Affiliations :
Department of Experimental Psychology, Justus Liebig University Giessen, 35394 Giessen, Germany, and Center for Mind, Brain and Behavior, Universities of Marburg, Giessen and Darmstadt, Germany. Electronic address: roland.w.fleming@psychol.uni-giessen.de.
Publications dans "Perception visuelle" :
2 publications dans cette catégorie
Affiliations :
Department of Psychology, Glendon College; and Center for Vision Research, York University, Toronto, Canada; email: patcav1@yorku.ca.
Publications dans "Perception visuelle" :
2 publications dans cette catégorie
Affiliations :
Department of Psychology, Justus Liebig University Giessen, Giessen, Germany.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Laboratory of Experimental Psychology, Department of Brain and Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Tiensestraat 102 - box 3711, 3000, Leuven, Belgium. eline.vangeert@kuleuven.be.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Department of Linguistics and Cognitive Science, University of Delaware, Newark, DE, USA. alon@udel.edu; https://pal.lingcogsci.udel.edu/.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Department of Linguistics and Philosophy, Massachusetts Institute of Technology, Cambridge, MA, USA. ejgr@mit.edu; https://sites.google.com/site/greenedwinj/.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Department of Psychological and Brain Sciences, Johns Hopkins University, Baltimore, MD, USA. chaz@jhu.edu; https://perception.jhu.edu/.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Department of Psychiatry, Service of General Psychiatry, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Laboratory of Cognitive Neuroscience, Brain Mind Institute, Faculty of Life Sciences, Swiss Federal Institute of Technology, Geneva, Switzerland.
Center for Neuroprosthetics, Faculty of Life Sciences, Swiss Federal Institute of Technology, Geneva, Switzerland.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Department of Psychiatry, Service of General Psychiatry, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Center for Neuroprosthetics, Faculty of Life Sciences, Swiss Federal Institute of Technology, Geneva, Switzerland.
CNRS, LPNC UMR 5105, Université Grenoble Alpes, Grenoble, France.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Lifeline Research Foundation, Lifeline Australia, Deakin ACT, Australia.
School of Health and Human Sciences, Southern Cross University, Lismore NSW, Australia.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Department of Mechanical Engineering and Automation, Northeastern University, Shenyang, China.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Institut de Neurosciences des Systèmes (INS), Inserm (U1106), Aix Marseille University, Marseille, France.
Publications dans "Perception visuelle" :
A mechanistic understanding of uncommon immune outcomes such as resistance to infection has led to the development of novel therapies. Using gene level analytic methods, we previously found distinct m...
Using transcript isoform analyses, we aimed to identify novel RSTR-associated genes hypothesizing that previous gene-level differential expression analysis obscures isoform-specific differences that c...
Monocytes from 49 RSTR versus 52 subjects with latent Mtb infection (LTBI) were infected with M. tuberculosis (H37Rv) or left unstimulated (media) prior to RNA isolation and sequencing. RSTR-associate...
We identified 81 differentially expressed transcripts (DETs) in 70 genes (FDR <0.05) comparing RSTR and LTBI phenotypes with the majority (n = 79 DETs) identified under Mtb-stimulated conditions. Seve...
Transcript isoform-specific analyses identify transcriptional associations, such as those associated with resistance to TST/IGRA conversion, that are obscured when using gene-level approaches. These f...
Heavy exposure to Mycobacterium tuberculosis, the etiologic agent of tuberculosis (TB) and among the top infectious killers worldwide, results in infection that is cleared, contained, or progresses to...
Establishing diagnosis of latent and active histoplasmosis is challenging. Interferon gamma-release assays (IGRAs) may provide evidence of latent and active infection. An enzyme-linked immunospot (ELI...
Diabetes mellitus (DM) patients with latent tuberculosis infection (LTBI) have an increased risk of developing active tuberculosis (TB) due to impaired immunity. The performance of currently available...
A prospective study was conducted to investigate the status of LTBI in patients with confirmed T2DM. At the baseline survey, the prevalence of LTBI was tested using interferon-gamma release assay (IGR...
A total of 404 participants with T2DM were included in the study. At baseline, after excluding active TB, the prevalence of LTBI identified by TST (≥ 10 mm), C-TST (≥ 5 mm) and IGRA (≥ 0.35 IU/ml) wer...
In studied patients with T2DM, C-TST showed higher consistency with IGRA as compared to TST. The present of conversion observed in serial testing suggested that boosting effect of skin testing should ...
The aim of this study was to evaluate the prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation candidates, using tuberculin skin test and QuantiFERON-TB...
The interferon-gamma (IFN-γ) release assay (IGRA) is an important laboratory diagnosis for latent Mycobacterium tuberculosis (TB) infection. The TB-IGRA measures the release of IFN-γ from peripheral b...
We have analyzed the clinical data of 776 children who are underwent TB-IGRA testing in the Department of Allergy and Rheumatology of Guangzhou Women and Children's Medical Center from 2018 to 2020. T...
The TB Ag-NL levels were significantly higher in patients with active SLE than those in inactive SLE (p = 0.0002). The TB Ag-NL levels were positively correlated with the SLE disease activity index (S...
The detection of IFN-γ release levels by the TB-IGRA may be useful to assess SLE disease activity in pediatric patients with active SLE....
Although the Interferon Gamma Release Assays (IGRA) is often used to identify latent tuberculosis, it also plays a crucial role in diagnosing active extrapulmonary tuberculosis. Some studies have asse...
We searched PubMed, Embase, and Cochran databases. We obtained literature related to the diagnosis of OATB by IGRA, and the retrieval period was from the establishment of the database to June 2021. Th...
We included seven studies involving 643 subjects in diagnosing OATB by IGRA. The comprehensive sensitivity and specificity were 0.84 (95% CI, 0.70-0.92) and 0.78 (95% CI, 0.66-0.87), respectively. The...
In blood samples, the diagnostic accuracy of IGRAS is poor in patients with suspected OAT. We conclude that IGRA may not be appropriate for patients with OATB....
Latent tuberculosis is prevalent in HIV-infected people and has an impact on the progression of AIDS. The aim of this study is to match a more accurate IGRA method for the better detection of latent t...
Interferon-gamma release assays (IGRAs) are approved for children ≥2 years old to aid in diagnosis of Mycobacterium tuberculosis (TB) infection and disease. Tuberculin skin tests (TSTs) continue to be...
We performed a retrospective cohort study of IGRA use in patients <2 years old in 2 large Boston healthcare systems. The primary outcome was the proportion of valid versus invalid/indeterminate IGRA r...
A total of 321 IGRA results were analyzed; 308 tests (96%) were valid and 13 (4%) were invalid/indeterminate. Thirty-seven IGRAs were obtained in immunocompromised patients; the proportion of invalid/...
The high proportion of valid IGRA test results in patients <2 years of age in a low TB prevalence setting in combination with the known logistical and interpretation challenges associated with TSTs su...
To predict protective immunity to SARS-CoV-2, cellular immunity seems to be more sensitive than humoral immunity. Through an Interferon-Gamma (IFN-γ) Release Assay (IGRA), we show that, despite a mark...